Cipla Ltd.

Cipla Medpro, 100%-owned by Cipla, has been awarded R2 billion share of the South African Government’s 2015-17 National ARV tender. The contract is effective from the April 1, 2015 and will run for a period of three years.

This latest Government tender win is the third in the last year for the growing pharmaceutical company, and follows Cipla Medpro winning a R280 million state therapeutic drug tender (August 2014), a R345 million national respiratory tender (June 2014).

Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 170 countries. Its portfolio includes 2000 products in 65 therapeutic categories with one quality standard globally.